Cargando…
Assay development for determination of DZ2002, a new reversible SAHH inhibitor, and its acid metabolite DZA in blood and application to rat pharmacokinetic study
Methyl (S)-4-(6-amino-9H-purin-9-yl)-2-hydroxybutanoate (DZ2002) is a potent reversible inhibitor of S-adenosyl-L-homocysteine hydrolase (SAHH). Due to its ester structure, DZ2002 is rapidly hydrolyzed in rat blood to 4-(6-amino-9H-purin-9-yl)-2-hydroxybutyric acid (DZA) during and after blood sampl...
Autores principales: | Jia, Weiwei, Li, Jing, Du, Feifei, Sun, Yan, Xu, Fang, Wang, Fengqing, Olaleye, Olajide E., Chen, Danghui, Tang, Wei, Zuo, Jianping, Li, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355468/ https://www.ncbi.nlm.nih.gov/pubmed/30740254 http://dx.doi.org/10.1016/j.jpha.2018.09.001 |
Ejemplares similares
-
DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models
por: Zhang, Zongwang, et al.
Publicado: (2019) -
Functional Characterization of SlSAHH2 in Tomato Fruit Ripening
por: Yang, Lu, et al.
Publicado: (2017) -
Reversible SAHH inhibitor protects against glomerulonephritis in lupus-prone mice by downregulating renal α-actinin-4 expression and stabilizing integrin-cytoskeleton linkage
por: He, Shijun, et al.
Publicado: (2019) -
Metformin alters DNA methylation genome-wide via the H19/SAHH axis
por: Zhong, T, et al.
Publicado: (2017) -
Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines
por: Li, Chuan, et al.
Publicado: (2022)